Law / United States / Minnesota

Accessible prescription drug container labels: pharmacies must provide large print, Braille or other accessible labels on request

Minn. Stat. § 151.212, subdivision 4

In force since .

An accessibility requirements rule binding private bodies.

Instrument type
an act of a legislature
Obligation class
Disclosure

What it requires

  • If you are a pharmacy, make reasonable efforts to inform the public that an accessible prescription drug container label is available at no additional cost, on request of the patient or the patient's representative, to any patient who has difficulty seeing or reading standard printed labels on prescription drug containers (Minn. Stat. 151.212, subd. 4(a)(1)).
  • If you know that a patient has difficulty seeing or reading standard printed labels, tell the patient that an accessible label is available at no additional cost on request (Minn. Stat. 151.212, subd. 4(a)(2)).
  • When a patient asks for an accessible container label, provide it in large print or Braille, or by another method in the United States Access Board's best practices for access to prescription drug labeling information, as the patient's need and preference require, and make reasonable efforts to ensure patient safety and access while the label is produced (Minn. Stat. 151.212, subd. 4(b)).
  • Make the accessible label last at least the duration of the prescription, carry the information required under subdivisions 1 and 2, provide it in a timely manner relative to the industry standard time to produce it, and conform it to the Access Board's best practices for large print and Braille labels (Minn. Stat. 151.212, subd. 4(c)).
  • From , be able to provide an accessible container label in that timely manner (Minn. Stat. 151.212, subd. 4(f)).

These lines are LexLint's reading of the law's text.

What this law does

Drafted with AI

Drafted with AI from the cited sources under the direction of UnGovr staff. UnGovr holds editorial responsibility for this page. How this site is made

Research summary

Legal information, not legal advice. This is LexLint's own research summary of a public legal source, and it creates no attorney-client relationship. For decisions that matter, consult qualified counsel in the relevant jurisdiction. About LexLint

Section 151.212, subdivision 4, requires a pharmacy that receives a request for an accessible prescription drug container label to provide the label in large print or Braille, or by another method in the best practices of the United States Access Board, depending on the need and preference of the patient. On and after , all pharmacies must be able to provide an accessible prescription drug container label in the timely manner that section 151.212, subdivision 4, requires.

The Board of Pharmacy may impose a civil penalty not exceeding $10,000 for each separate violation of a licensee's prohibited conduct. A pharmacy's violation of any provision of the pharmacy chapter is grounds for disciplinary action by the Board of Pharmacy.

Back to the example  ·  Lint your app

Page updated .